Cover Image
市場調查報告書

咽喉瘤:全球臨床實驗趨勢

Pharyngeal Neoplasm Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 329831
出版日期 內容資訊 英文 95 Pages
訂單完成後即時交付
價格
Back to Top
咽喉瘤:全球臨床實驗趨勢 Pharyngeal Neoplasm Global Clinical Trials Review, H1, 2015
出版日期: 2015年03月27日 內容資訊: 英文 95 Pages
簡介

本報告提供咽喉瘤治療藥的臨床試驗相關基本資料和數據,提供您各地區,各階段,各進展狀況的實施數量,並彙整代表性贊助商,開發中的治療藥資訊,全球各國的主要企業·機關的臨床試驗之進展,有潛力的藥劑比較等資訊。

簡介

  • 咽喉瘤
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主5國的臨床實驗數量
    • 歐洲主5國的臨床實驗數量
    • 北美的主要國家的臨床實驗數量
    • 中東·非洲的主要5個國家臨床實驗數量
    • 中南美的主要國家的臨床實驗數量

G7各國臨床實驗數量:腫瘤治療藥臨床實驗上咽喉瘤的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:腫瘤治療藥臨床實驗上咽喉瘤的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

咽喉瘤治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Sanofi
    • F. Hoffmann-La Roche Ltd.
    • E. Merck KG
    • C. H. Boehringer Sohn AG & Co. KG
    • GlaxoSmithKline plc
    • Merck & Co., Inc.
    • Oncolytics Biotech Inc.
    • Celgene Corporation
    • Bristol-Myers Squibb Company
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Cancer Institute
    • Sun Yat-sen University
    • Baylor College of Medicine
    • Radiation Therapy Oncology Group
    • Sun Yat-Sen University Cancer Center
    • Chinese University of Hong Kong
    • FUDAN University
    • Memorial Sloan Kettering Cancer Center
    • European Organization for Research and Treatment of Cancer

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2621CTIDB

GlobalData's clinical trial report, "Pharyngeal Neoplasm Global Clinical Trials Review, H1, 2015" provides data on the Pharyngeal Neoplasm clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pharyngeal Neoplasm. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pharyngeal Neoplasm. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Pharyngeal Neoplasm
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Pharyngeal Neoplasm to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Pharyngeal Neoplasm to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Pharyngeal Neoplasm
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Pharyngeal Neoplasm Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • E. Merck KG
      • Clinical Trial Overview of E. Merck KG
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Oncolytics Biotech Inc.
      • Clinical Trial Overview of Oncolytics Biotech Inc.
      • Celgene Corporation
      • Clinical Trial Overview of Celgene Corporation
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Sun Yat-sen University
      • Clinical Trial Overview of Sun Yat-sen University
      • Baylor College of Medicine
      • Clinical Trial Overview of Baylor College of Medicine
      • Radiation Therapy Oncology Group
      • Clinical Trial Overview of Radiation Therapy Oncology Group
      • Sun Yat-Sen University Cancer Center
      • Clinical Trial Overview of Sun Yat-Sen University Cancer Center
      • Chinese University of Hong Kong
      • Clinical Trial Overview of Chinese University of Hong Kong
      • FUDAN University
      • Clinical Trial Overview of FUDAN University
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • European Organization for Research and Treatment of Cancer
      • Clinical Trial Overview of European Organization for Research and Treatment of Cancer
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials by Region, 2015*
  • Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Pharyngeal Neoplasm to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Pharyngeal Neoplasm Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Pharyngeal Neoplasm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Pharyngeal Neoplasm to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Pharyngeal Neoplasm Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Pharyngeal Neoplasm Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Pharyngeal Neoplasm Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Pharyngeal Neoplasm Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Pharyngeal Neoplasm Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Pharyngeal Neoplasm Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Oncolytics Biotech Inc., 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-Sen University Cancer Center, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2015*

List of Figures

  • Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Pharyngeal Neoplasm to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Pharyngeal Neoplasm Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Pharyngeal Neoplasm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Pharyngeal Neoplasm to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Pharyngeal Neoplasm Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Pharyngeal Neoplasm Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Pharyngeal Neoplasm Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Pharyngeal Neoplasm Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Pharyngeal Neoplasm Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top